SAN DIEGO --(BUSINESS WIRE)--Feb. 13, 2020-- DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter and fiscal year ended December 31, 2019 . Fourth Quarter 2019 Highlights: Revenue grew 37% versus the same quarter of the prior year to $462.8 million U.S.

SAN DIEGO --(BUSINESS WIRE)--Jan. 21, 2020-- DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its fourth quarter and full year 2019 financial results after market close on Thursday, February 13, 2020 . Management will hold a conference call to review the company's fourth quarter

SAN DIEGO --(BUSINESS WIRE)--Jan. 13, 2020-- DexCom, Inc. (Nasdaq: DXCM), the leader in continuous glucose monitoring (“CGM”), today reported that it expects preliminary, unaudited revenue for the fourth quarter ended December 31, 2019 to be approximately $457 million , an increase of 35% over the

SAN DIEGO --(BUSINESS WIRE)--Jan. 6, 2020-- DexCom, Inc. (NASDAQ:DXCM) today announced that Kevin Sayer , Chairman, President and Chief Executive Officer, will present an update on the company at the 38 th annual J.P. Morgan Healthcare Conference on January 13, 2020 .